Cara Therapeutics (CARA) Net margin US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | -383.0% | -199.2% | -565.2% | -565.2% | -993.0% | -782.9% | ||
| Changes by years, y/y, % | -389pp | +184pp | -366pp | 0pp | -428pp | +13.2% | |||
Cara Therapeutics. Net margin, %
Cara Therapeutics. Net margin, changes, pp
Cara Therapeutics (CARA) Net margin US GAAP (quarter values) |
||||||||
| 2024Q4 | 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | LTM ? | |||
| Net margin, % | ? | -527.8% | -191.0% | -465.1% | -782.9% | |||
| Changes by years, y/y, % | +549pp | +1 247pp | +2 020pp | +488pp | +63pp | |||
| Changes by quarters, q/q, % | -40pp | +337pp | +191pp | |||||